Gainplan »

Nektar Therapeutics shares owned by Gainplan

Quarter-by-quarter ownership of Nektar Therapeutics (NKTR) shares owned by Gainplan from 13F filings

Historical chart of Gainplan investment in Nektar Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Nektar Therapeutics held by Gainplan consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nektar Therapeutics by Gainplan

Quarter filed Position value Share count Share price at filing
2025-09-30 $287k 5.0k 56.90
2025-06-30 $388k 15k 25.84

More positions owned by Gainplan

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Pimco Etf Tr Enhan Shrt Ma Ac (MINT)
Ishares Tr Russell 2000 Etf (IWM)
Neos Etf Trust Neos Enh Inc 1-3 (CSHI)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Ishares Bitcoin Trust Etf Shs Ben Int (IBIT)
Qxo Com New (QXO)
Proshares Tr Ultrapro Short S (SPXU)
Vanguard Index Fds Large Cap Etf (VV)
Kraneshares Trust Csi Chi Internet (KWEB)
Vanguard Index Fds Mid Cap Etf (VO)
Spdr Index Shs Fds Portfolio Emg Mk (SPEM)
Tesla Motors (TSLA)
Spdr Index Shs Fds Portfolio Devlpd (SPDW)
Neos Etf Trust Neos S&p 500 Hi (SPYI)

View all positions for Gainplan

Top funds holding Nektar Therapeutics

Susquehanna International
BVF
Vanguard Group
Citadel Advisors
Farallon Capital Management
BlackRock
Millennium Management
Two Sigma Investments
Nantahala Capital Management
22NW
Emerald Advisers
Leucadia National Corporation
Dr. Jeffrey R. Jay, M.D.
PRIMECAP Management Company
Renaissance Technologies

View all funds holding Nektar Therapeutics